MARSHALL WACE ASIA Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 132 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE ASIA Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2021$1,305,000
+374.5%
33,243
+241.8%
0.03%
+366.7%
Q1 2021$275,000
-56.9%
9,727
-58.0%
0.01%
-57.1%
Q2 2020$638,000
+6280.0%
23,139
+4169.2%
0.01%
Q1 2020$10,000
-85.9%
542
-86.4%
0.00%
-100.0%
Q3 2019$71,000
-77.8%
3,976
-62.6%
0.00%
-81.8%
Q2 2018$320,00010,6200.01%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Karst Peak Capital Ltd 225,000$5,195,00019.07%
AIA Investment Management Private Ltd 354,035$8,175,0003.37%
Bellevue Group AG 440,169$10,164,0000.67%
Prince Street Capital Management LLC 81,400$1,879,0000.46%
PRUDENTIAL PLC 4,112,412$94,956,0000.38%
OppenheimerFunds, Inc. 4,265,943$98,501,0000.14%
Fullerton Fund Management Co Ltd. 9,941$230,0000.13%
SECTORAL ASSET MANAGEMENT INC 31,628$730,0000.10%
SCHRODER INVESTMENT MANAGEMENT GROUP 1,803,955$41,653,0000.08%
Sands Capital Management 830,520$19,177,0000.07%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders